Henderson Jane

Chief Financial OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$132K
Net Open-Market Flow
-$132K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)1K$66.15$73K183K
Feb 2, 2026Sell(S)792$65.21$52K185K
Feb 2, 2026Sell(S)100$66.89$7K183K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-010453) within minutes of acceptance. Every field above traces to the original document. Verify it directly: